Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

David Raben

Concepts (620)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
56
2026
563
6.680
Why?
Carcinoma, Squamous Cell
50
2021
627
4.980
Why?
Quinazolines
20
2015
267
2.380
Why?
Prostatic Neoplasms
22
2021
972
2.310
Why?
ErbB Receptors
20
2020
636
2.130
Why?
Radiotherapy, Intensity-Modulated
8
2018
143
1.860
Why?
Combined Modality Therapy
44
2020
1269
1.820
Why?
Oropharyngeal Neoplasms
12
2019
56
1.800
Why?
Antineoplastic Combined Chemotherapy Protocols
18
2026
1996
1.660
Why?
Radiotherapy, Conformal
10
2015
75
1.530
Why?
Radiotherapy
13
2019
209
1.510
Why?
Cetuximab
15
2020
110
1.510
Why?
Antineoplastic Agents
28
2017
2218
1.420
Why?
Carcinoma, Non-Small-Cell Lung
15
2022
1194
1.420
Why?
Chemoradiotherapy
16
2020
238
1.330
Why?
Brachytherapy
5
2016
132
1.220
Why?
Lung Neoplasms
17
2022
2674
1.170
Why?
Diglycerides
14
2016
66
1.130
Why?
Radiosurgery
11
2022
398
1.130
Why?
Radiation Oncology
5
2022
83
1.120
Why?
Neoplasm Staging
23
2018
1486
1.060
Why?
Radiotherapy Dosage
22
2021
289
1.050
Why?
Neoplasm Proteins
5
2020
443
0.920
Why?
Laryngeal Neoplasms
5
2017
36
0.890
Why?
Chemotherapy, Adjuvant
9
2020
429
0.860
Why?
Radiotherapy Planning, Computer-Assisted
7
2018
150
0.810
Why?
Melanoma
5
2018
764
0.800
Why?
Phthalazines
3
2020
63
0.780
Why?
Receptors, Vascular Endothelial Growth Factor
5
2007
109
0.780
Why?
Radiation Injuries
7
2021
149
0.770
Why?
Immunotherapy
5
2022
669
0.740
Why?
Biomarkers, Tumor
9
2022
1334
0.730
Why?
Diacylglycerol Kinase
3
2016
5
0.720
Why?
Piperidines
7
2015
223
0.710
Why?
Dancing
1
2022
19
0.700
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2020
137
0.700
Why?
DNA Repair
4
2020
254
0.690
Why?
Piperazines
3
2020
367
0.680
Why?
Thrombin
9
2001
174
0.660
Why?
Neovascularization, Pathologic
5
2006
285
0.650
Why?
Antibodies, Monoclonal
11
2022
1511
0.640
Why?
Aged
64
2026
26251
0.640
Why?
Humans
145
2026
145625
0.640
Why?
Angiogenesis Inhibitors
4
2006
238
0.630
Why?
Poly (ADP-Ribose) Polymerase-1
1
2020
55
0.620
Why?
Signal Transduction
24
2019
5234
0.620
Why?
Neoplasm Recurrence, Local
13
2026
1156
0.620
Why?
Cisplatin
13
2020
346
0.610
Why?
Middle Aged
63
2026
36359
0.580
Why?
Phosphatidylcholines
8
2016
130
0.580
Why?
Xenograft Model Antitumor Assays
13
2020
928
0.570
Why?
Mice, Nude
15
2020
665
0.570
Why?
Cyclin-Dependent Kinase Inhibitor p16
4
2016
74
0.570
Why?
Glottis
2
2017
20
0.550
Why?
Organ Sparing Treatments
2
2015
37
0.540
Why?
Receptor, EphB4
4
2019
33
0.540
Why?
Survival Rate
18
2019
2078
0.530
Why?
Stomatitis
6
2021
15
0.520
Why?
Papillomavirus Infections
5
2022
345
0.520
Why?
Smokers
1
2018
139
0.510
Why?
Neoplasms
10
2018
2944
0.510
Why?
Mouth Neoplasms
4
2019
90
0.500
Why?
Unilamellar Liposomes
1
2016
8
0.490
Why?
Enzyme Assays
1
2016
25
0.490
Why?
Intracellular Membranes
1
2016
76
0.490
Why?
Cell Line, Tumor
23
2020
3538
0.470
Why?
Skin Neoplasms
2
2015
805
0.470
Why?
Prognosis
22
2022
4331
0.470
Why?
Molecular Targeted Therapy
6
2019
446
0.470
Why?
Male
76
2026
73014
0.470
Why?
Papillomaviridae
7
2019
113
0.470
Why?
Proton Therapy
2
2017
16
0.460
Why?
Animals
57
2021
38030
0.450
Why?
Mucositis
4
2021
20
0.450
Why?
Proportional Hazards Models
15
2019
1318
0.450
Why?
Radiation Tolerance
6
2019
101
0.440
Why?
Submandibular Gland
1
2015
20
0.440
Why?
Aged, 80 and over
25
2019
8351
0.440
Why?
Prostate-Specific Antigen
7
2016
162
0.430
Why?
Medically Uninsured
1
2015
134
0.430
Why?
Ephrin-B2
3
2019
45
0.420
Why?
Adenosine Triphosphate
1
2016
494
0.400
Why?
Female
69
2026
79080
0.400
Why?
Cell Nucleus
4
2004
584
0.400
Why?
Nuclear Envelope
3
2000
47
0.390
Why?
Esophagus
2
2012
260
0.390
Why?
Treatment Outcome
28
2019
11744
0.390
Why?
Epidermal Growth Factor
8
2005
157
0.390
Why?
Disease-Free Survival
15
2017
777
0.380
Why?
Insurance, Health
1
2015
315
0.370
Why?
Androgen Antagonists
4
2021
91
0.370
Why?
Kaplan-Meier Estimate
12
2019
959
0.360
Why?
Phospholipids
7
2000
215
0.360
Why?
Clinical Trials as Topic
9
2022
1062
0.360
Why?
Tumor Microenvironment
4
2021
745
0.360
Why?
Esophagitis
1
2012
68
0.350
Why?
Phosphatidylinositols
7
2000
59
0.350
Why?
Antibodies, Monoclonal, Humanized
8
2026
992
0.340
Why?
Gene Expression Regulation, Neoplastic
6
2020
1429
0.340
Why?
Medicaid
1
2015
472
0.340
Why?
Remote Consultation
1
2012
67
0.330
Why?
Radiation-Sensitizing Agents
4
2019
43
0.330
Why?
Mice
32
2021
18266
0.330
Why?
Facial Neoplasms
1
2011
19
0.330
Why?
Antineoplastic Agents, Immunological
4
2022
200
0.330
Why?
Lymph Nodes
6
2019
511
0.320
Why?
Adult
36
2026
40821
0.310
Why?
Follow-Up Studies
13
2019
5397
0.310
Why?
Peptides, Cyclic
3
2020
276
0.310
Why?
Urinary Bladder
2
2010
194
0.310
Why?
Comparative Effectiveness Research
1
2011
170
0.310
Why?
Boronic Acids
1
2010
37
0.310
Why?
Glycerides
5
1993
16
0.300
Why?
SEER Program
8
2019
233
0.300
Why?
Vascular Endothelial Growth Factors
2
2009
77
0.300
Why?
Smad4 Protein
2
2020
33
0.300
Why?
B7-H1 Antigen
3
2021
245
0.290
Why?
Pyrazines
1
2010
94
0.290
Why?
Adenoma
1
2011
209
0.280
Why?
Counseling
1
2012
403
0.280
Why?
Smad7 Protein
3
2021
20
0.280
Why?
Propensity Score
5
2017
370
0.280
Why?
Neoplasm Grading
5
2016
313
0.280
Why?
Carcinoma, Renal Cell
1
2011
229
0.280
Why?
Retrospective Studies
20
2021
17291
0.270
Why?
Radiotherapy, Adjuvant
7
2017
222
0.270
Why?
Pancreatic Neoplasms
3
2019
944
0.270
Why?
ras Proteins
1
2009
148
0.270
Why?
Proto-Oncogene Proteins
3
2009
615
0.270
Why?
Nomograms
2
2018
59
0.260
Why?
Organs at Risk
4
2015
37
0.260
Why?
Protein-Tyrosine Kinases
6
2015
429
0.260
Why?
T-Lymphocytes, Regulatory
3
2019
411
0.260
Why?
Fibroblasts
8
2001
1033
0.250
Why?
Cricetinae
9
2001
295
0.250
Why?
United States
18
2019
16041
0.250
Why?
Feasibility Studies
5
2015
1125
0.250
Why?
Organophosphorus Compounds
2
2005
84
0.250
Why?
Survival Analysis
9
2019
1372
0.250
Why?
Histocompatibility Antigens Class I
2
2019
207
0.240
Why?
Kidney Neoplasms
1
2011
417
0.240
Why?
Mesoderm
1
2007
147
0.240
Why?
Neoplasms, Unknown Primary
1
2006
20
0.240
Why?
Intestines
1
2009
351
0.230
Why?
Neoplasms, Experimental
3
2015
163
0.230
Why?
Neoplasm Metastasis
4
2018
693
0.230
Why?
Technology, Radiologic
1
2005
6
0.220
Why?
Radiation, Ionizing
7
2012
84
0.220
Why?
Patient Acceptance of Health Care
1
2012
880
0.220
Why?
Mitogens
4
2000
55
0.220
Why?
Dose-Response Relationship, Radiation
5
2020
141
0.220
Why?
Salivary Gland Neoplasms
2
2016
39
0.210
Why?
Kinetics
9
2016
1553
0.210
Why?
Maximum Tolerated Dose
3
2015
216
0.210
Why?
Drug Resistance, Neoplasm
2
2007
889
0.210
Why?
Induction Chemotherapy
2
2017
87
0.200
Why?
Type C Phospholipases
2
1997
69
0.200
Why?
Urinary Bladder Neoplasms
3
2015
257
0.200
Why?
Stress, Psychological
1
2012
1169
0.200
Why?
Immunohistochemistry
9
2019
1709
0.200
Why?
Transforming Growth Factor beta
3
2021
466
0.190
Why?
Apoptosis
9
2020
2436
0.190
Why?
DNA Mutational Analysis
2
2018
409
0.190
Why?
Phosphatidylserines
3
2016
62
0.190
Why?
Mutation
6
2013
4082
0.190
Why?
Risk Assessment
6
2019
3678
0.180
Why?
Tonsillar Neoplasms
2
2015
10
0.180
Why?
Drug Synergism
3
2020
353
0.180
Why?
Receptors, Thrombin
2
2000
13
0.180
Why?
Disease Models, Animal
9
2020
4565
0.180
Why?
Proto-Oncogene Proteins p21(ras)
2
2017
250
0.180
Why?
Taxoids
4
2015
115
0.180
Why?
Membrane Lipids
2
1994
81
0.180
Why?
Hydrolysis
7
2000
195
0.180
Why?
Toes
1
2022
16
0.180
Why?
Prostatectomy
3
2014
93
0.180
Why?
Circulating Tumor DNA
1
2022
50
0.180
Why?
Cricetulus
6
2000
115
0.170
Why?
Radiotherapy, Image-Guided
2
2019
40
0.170
Why?
DNA, Neoplasm
2
2020
160
0.170
Why?
Keratinocytes
3
2017
190
0.170
Why?
Databases, Factual
6
2017
1481
0.170
Why?
Enzyme Inhibitors
5
2005
820
0.170
Why?
Paclitaxel
3
2012
258
0.170
Why?
Rectum
2
2014
180
0.160
Why?
Transcriptome
2
2018
1066
0.160
Why?
Models, Biological
6
2018
1758
0.160
Why?
National Cancer Institute (U.S.)
5
2019
55
0.160
Why?
Epithelial Cells
1
2007
1118
0.160
Why?
DNA End-Joining Repair
1
2020
22
0.160
Why?
Mice, Inbred BALB C
6
2019
1244
0.160
Why?
Time Factors
10
2017
7079
0.160
Why?
Proof of Concept Study
1
2020
89
0.160
Why?
Neoplasm Transplantation
4
2018
238
0.160
Why?
Clone Cells
1
2020
259
0.160
Why?
Chemoradiotherapy, Adjuvant
2
2017
44
0.150
Why?
Radiography
4
2010
856
0.150
Why?
Radioimmunotherapy
1
2019
25
0.150
Why?
Cell Proliferation
8
2020
2497
0.150
Why?
Cohort Studies
7
2021
6045
0.150
Why?
Protein Synthesis Inhibitors
1
2020
48
0.150
Why?
Carcinoma, Adenoid Cystic
2
2017
18
0.150
Why?
Carcinoma, Mucoepidermoid
2
2017
17
0.150
Why?
Phosphorylation
4
2016
1717
0.150
Why?
Chemokines, CXC
1
2019
68
0.150
Why?
Lymphocyte Depletion
1
2019
135
0.150
Why?
Drosophila melanogaster
2
2012
237
0.150
Why?
Tumor Escape
1
2019
50
0.140
Why?
Phosphatidylethanolamines
2
2016
78
0.140
Why?
Tongue Neoplasms
2
2009
26
0.140
Why?
Alphapapillomavirus
2
2016
35
0.140
Why?
Receptor, EphB3
1
2018
4
0.140
Why?
Morpholines
2
2018
130
0.140
Why?
Genetic Heterogeneity
1
2019
66
0.140
Why?
Dose-Response Relationship, Drug
6
2010
2018
0.140
Why?
Hepatitis A Virus Cellular Receptor 2
1
2018
27
0.140
Why?
Chromosome Aberrations
1
2019
167
0.130
Why?
Hyperlipidemias
1
2019
120
0.130
Why?
Thyroid Carcinoma, Anaplastic
1
2018
37
0.130
Why?
Up-Regulation
4
2019
840
0.130
Why?
STAT3 Transcription Factor
1
2019
214
0.130
Why?
Class I Phosphatidylinositol 3-Kinases
1
2018
109
0.130
Why?
CTLA-4 Antigen
1
2018
105
0.130
Why?
Radiation Injuries, Experimental
2
2018
20
0.130
Why?
Lower Extremity
1
2022
449
0.130
Why?
Papillomavirus E7 Proteins
1
2017
11
0.130
Why?
Patient Selection
2
2019
720
0.130
Why?
Aminopyridines
1
2018
128
0.130
Why?
Health Knowledge, Attitudes, Practice
1
2006
1403
0.130
Why?
Organ Specificity
1
2018
306
0.130
Why?
Gene Deletion
1
2019
384
0.130
Why?
Carcinoma, Adenosquamous
1
2017
9
0.130
Why?
Cell Line
8
2001
2809
0.130
Why?
Nose Neoplasms
1
2017
22
0.130
Why?
Lymphocytes, Tumor-Infiltrating
1
2018
155
0.130
Why?
Transplantation, Heterologous
4
2006
165
0.130
Why?
Phospholipase D
2
1997
7
0.120
Why?
Paranasal Sinus Neoplasms
1
2017
29
0.120
Why?
Cell Cycle
5
2021
595
0.120
Why?
Liver Neoplasms
2
2018
774
0.120
Why?
GTP-Binding Proteins
1
1997
150
0.120
Why?
Neoplasms, Second Primary
2
2008
103
0.120
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2007
86
0.120
Why?
Radiodermatitis
1
2016
11
0.120
Why?
Deoxycytidine
2
2008
219
0.120
Why?
Prospective Studies
7
2019
8087
0.120
Why?
Drug Eruptions
1
2016
28
0.120
Why?
Programmed Cell Death 1 Receptor
1
2018
268
0.120
Why?
Antibodies
1
2018
395
0.120
Why?
Cell Movement
2
2018
950
0.120
Why?
Skin Ulcer
1
2015
15
0.120
Why?
Database Management Systems
1
2016
50
0.120
Why?
Isoenzymes
1
2016
294
0.120
Why?
Neoplastic Stem Cells
1
2020
402
0.110
Why?
Lymphatic Metastasis
5
2019
335
0.110
Why?
Drug Screening Assays, Antitumor
3
2012
194
0.110
Why?
Radiometry
1
2015
56
0.110
Why?
Wound Healing
1
2018
348
0.110
Why?
Surface Properties
1
2016
383
0.110
Why?
Cell Transformation, Neoplastic
1
1997
314
0.110
Why?
Enzyme Activation
4
2001
758
0.110
Why?
Neutrophils
2
2019
1132
0.110
Why?
Blotting, Western
5
2013
1176
0.110
Why?
Mammals
1
2016
287
0.110
Why?
Analysis of Variance
5
2019
1293
0.110
Why?
Neoplasms, Multiple Primary
1
2015
57
0.110
Why?
Radiation Protection
1
2015
41
0.110
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2019
448
0.110
Why?
Carcinoma, Papillary
1
2015
83
0.110
Why?
Deglutition Disorders
2
2016
159
0.110
Why?
Neoplasm Invasiveness
3
2017
503
0.110
Why?
Hydroxamic Acids
1
2015
95
0.110
Why?
Cell Division
3
2007
735
0.100
Why?
Stromal Cells
1
2014
123
0.100
Why?
Fibroblast Growth Factor 2
2
2011
93
0.100
Why?
Protein Binding
2
2016
2239
0.100
Why?
Colorectal Neoplasms
2
2019
870
0.100
Why?
Randomized Controlled Trials as Topic
5
2017
1754
0.100
Why?
Tumor Burden
4
2018
326
0.100
Why?
Thyroid Neoplasms
1
2018
380
0.100
Why?
Multivariate Analysis
5
2017
1531
0.100
Why?
Platelet-Derived Growth Factor
2
1990
85
0.100
Why?
Hedgehog Proteins
1
2014
194
0.100
Why?
Quality of Life
4
2018
3187
0.100
Why?
CD8-Positive T-Lymphocytes
1
2019
929
0.090
Why?
Tumor Cells, Cultured
4
2020
878
0.090
Why?
DNA, Viral
2
2015
352
0.090
Why?
Radiation-Protective Agents
1
2012
16
0.090
Why?
Colorado
2
2015
4588
0.090
Why?
DNA Replication
4
2000
248
0.090
Why?
Phosphatidic Acids
1
1992
8
0.090
Why?
G1 Phase
2
2005
64
0.090
Why?
Salvage Therapy
2
2011
163
0.090
Why?
Metalloporphyrins
1
2012
62
0.090
Why?
Larynx
1
2012
56
0.090
Why?
Saccharomyces cerevisiae
1
2016
584
0.090
Why?
DNA Methylation
1
2017
721
0.090
Why?
Diarrhea
2
2010
190
0.090
Why?
Carbachol
1
1991
17
0.080
Why?
Radiation Pneumonitis
1
2011
31
0.080
Why?
Brain Neoplasms
2
2018
1324
0.080
Why?
Autocrine Communication
1
2011
38
0.080
Why?
Adenocarcinoma
2
2009
927
0.080
Why?
Maytansine
1
2011
18
0.080
Why?
Telephone
1
2012
175
0.080
Why?
Drug Administration Schedule
2
2010
782
0.080
Why?
Device Removal
1
2012
149
0.080
Why?
Receptors, Fibroblast Growth Factor
1
2011
70
0.080
Why?
Mohs Surgery
1
2011
30
0.080
Why?
Protein Kinase Inhibitors
2
2010
982
0.080
Why?
Nerve Growth Factors
1
1991
79
0.080
Why?
Second Messenger Systems
1
1990
31
0.080
Why?
Protons
1
2011
96
0.080
Why?
Risk Factors
6
2019
10840
0.080
Why?
Flow Cytometry
3
2019
1160
0.080
Why?
Caspase 3
1
2011
240
0.080
Why?
Arachidonic Acid
3
1999
101
0.080
Why?
Triazines
1
2010
48
0.080
Why?
Pilot Projects
2
2015
1878
0.080
Why?
DNA Damage
3
2020
437
0.080
Why?
In Situ Hybridization, Fluorescence
4
2019
333
0.080
Why?
Bortezomib
1
2010
54
0.080
Why?
Lymphopenia
1
2010
62
0.080
Why?
Small Cell Lung Carcinoma
1
2011
125
0.080
Why?
Neoadjuvant Therapy
3
2022
474
0.070
Why?
Nausea
1
2010
111
0.070
Why?
Cell Hypoxia
1
2010
247
0.070
Why?
Prostaglandin D2
1
2009
22
0.070
Why?
Clinical Trials, Phase III as Topic
2
2015
116
0.070
Why?
Urination Disorders
1
2009
15
0.070
Why?
Lymphatic Irradiation
1
2009
11
0.070
Why?
Polymorphism, Restriction Fragment Length
1
2009
57
0.070
Why?
Cystitis
1
2009
24
0.070
Why?
Artifacts
1
2010
142
0.070
Why?
Gene Expression Profiling
4
2019
1790
0.070
Why?
Palladium
1
2009
18
0.070
Why?
Neutropenia
1
2010
153
0.070
Why?
Exanthema
1
2009
86
0.070
Why?
Radioisotopes
1
2009
37
0.070
Why?
Oligonucleotide Array Sequence Analysis
2
2009
751
0.070
Why?
Antioxidants
1
2012
544
0.070
Why?
Infusions, Intravenous
1
2010
429
0.070
Why?
Polymerase Chain Reaction
2
2009
1030
0.070
Why?
ATP-Binding Cassette Transporters
1
2009
115
0.070
Why?
Carcinoma
2
2011
225
0.070
Why?
Iodine Radioisotopes
1
2009
139
0.070
Why?
Cytotoxicity, Immunologic
2
2019
224
0.070
Why?
Heterografts
2
2019
143
0.070
Why?
Palliative Care
2
2010
1032
0.070
Why?
Gene Expression Regulation
1
2017
2591
0.070
Why?
Pelvis
1
2009
129
0.070
Why?
Patient Satisfaction
1
2012
698
0.070
Why?
Program Evaluation
1
2012
945
0.070
Why?
Social Support
1
2012
644
0.070
Why?
Carcinoma, Transitional Cell
1
2008
70
0.060
Why?
Immunoenzyme Techniques
2
2005
196
0.060
Why?
Disease Progression
4
2018
2857
0.060
Why?
Fatigue
1
2010
362
0.060
Why?
Glutathione
1
2009
369
0.060
Why?
Fluorouracil
1
2008
231
0.060
Why?
Gene Knockdown Techniques
2
2019
334
0.060
Why?
Predictive Value of Tests
4
2017
2097
0.060
Why?
Bone Neoplasms
2
2015
271
0.060
Why?
Cortactin
1
2006
7
0.060
Why?
Actin-Related Protein 2-3 Complex
1
2006
8
0.060
Why?
Adaptation, Psychological
1
2012
718
0.060
Why?
Rectal Neoplasms
1
2008
159
0.060
Why?
Positron-Emission Tomography
2
2006
342
0.060
Why?
Chromosomes, Human, Pair 11
1
2006
60
0.060
Why?
Respiratory Mucosa
1
2009
323
0.060
Why?
Double-Blind Method
1
2011
2064
0.060
Why?
Axilla
1
2006
51
0.060
Why?
Nutritional Support
1
2006
39
0.060
Why?
Erythropoietin
1
2007
100
0.060
Why?
Xanthones
1
2005
6
0.060
Why?
Protein Kinase C
2
2019
250
0.060
Why?
RNA Interference
2
2018
470
0.060
Why?
History, 21st Century
1
2006
224
0.060
Why?
Neutrons
1
2005
10
0.060
Why?
Particle Accelerators
1
2005
9
0.060
Why?
Resting Phase, Cell Cycle
1
2005
16
0.050
Why?
Sensitivity and Specificity
3
2016
1992
0.050
Why?
Imaging, Three-Dimensional
1
2009
578
0.050
Why?
Vascular Endothelial Growth Factor A
2
2005
543
0.050
Why?
History, 20th Century
1
2006
330
0.050
Why?
Controlled Clinical Trials as Topic
1
2004
26
0.050
Why?
Phosphatidylinositol 3-Kinases
2
2013
384
0.050
Why?
Electrons
1
2005
81
0.050
Why?
Mitosis
2
2011
194
0.050
Why?
Ki-67 Antigen
1
2004
119
0.050
Why?
Cross-Sectional Studies
1
2015
5875
0.050
Why?
Trypanosoma
2
1994
8
0.050
Why?
Glycosylphosphatidylinositols
2
1994
11
0.050
Why?
Necrosis
1
2004
243
0.050
Why?
Socioeconomic Factors
2
2019
1323
0.050
Why?
Radiotherapy, High-Energy
1
2003
17
0.050
Why?
Mice, Inbred C57BL
3
2021
6021
0.050
Why?
Algorithms
2
2015
1843
0.050
Why?
Etoposide
2
2015
169
0.050
Why?
Biomedical Research
1
2009
724
0.050
Why?
Genes, erbB-1
1
2002
21
0.050
Why?
Biological Products
2
2019
257
0.050
Why?
Biomarkers
3
2019
4329
0.040
Why?
Young Adult
2
2017
14240
0.040
Why?
Reproducibility of Results
3
2016
3396
0.040
Why?
Diagnosis, Differential
1
2006
1500
0.040
Why?
Gene Products, tat
1
2021
22
0.040
Why?
Glioblastoma
1
2005
349
0.040
Why?
Chemoprevention
1
2002
91
0.040
Why?
Macrophages
2
2019
1530
0.040
Why?
Mitogen-Activated Protein Kinases
2
2019
288
0.040
Why?
Protein Biosynthesis
2
2015
447
0.040
Why?
Active Transport, Cell Nucleus
1
2001
120
0.040
Why?
rhoA GTP-Binding Protein
1
2001
76
0.040
Why?
Logistic Models
2
2017
2112
0.040
Why?
Pain
1
2006
787
0.040
Why?
Cyclin D1
1
2000
64
0.040
Why?
Chromatography, Gas
2
1990
30
0.040
Why?
Peptide Chain Elongation, Translational
1
2020
18
0.040
Why?
Receptor, PAR-1
1
2000
17
0.040
Why?
Androgens
1
2021
179
0.040
Why?
Dogs
1
2021
516
0.040
Why?
Incidence
3
2016
2910
0.040
Why?
Interleukin-2 Receptor alpha Subunit
1
2019
82
0.040
Why?
Cell Death
2
2011
379
0.040
Why?
Choline
2
1991
134
0.040
Why?
Longitudinal Studies
2
2018
3005
0.040
Why?
Pyrimidine Nucleosides
1
2019
3
0.040
Why?
Mass Screening
1
2008
1300
0.040
Why?
Immunologic Factors
2
2016
244
0.040
Why?
Tomography, X-Ray Computed
2
2011
2766
0.040
Why?
Cyclin-Dependent Kinases
1
2000
121
0.040
Why?
Enteropeptidase
1
1999
2
0.040
Why?
Administration, Oral
1
2002
867
0.040
Why?
HSP90 Heat-Shock Proteins
1
2019
47
0.040
Why?
Myeloid-Derived Suppressor Cells
1
2019
77
0.040
Why?
Transforming Growth Factor beta1
1
2019
176
0.030
Why?
Forkhead Transcription Factors
1
2019
208
0.030
Why?
Lipids
1
2004
715
0.030
Why?
Luminescence
1
2018
37
0.030
Why?
Herpesvirus 1, Human
1
2019
87
0.030
Why?
Computer Simulation
2
2015
1014
0.030
Why?
Rats
3
2012
5574
0.030
Why?
DNA Primers
1
1999
487
0.030
Why?
Choline Kinase
1
1997
3
0.030
Why?
Fluorescent Antibody Technique
1
2018
345
0.030
Why?
Phosphatidate Phosphatase
1
1997
4
0.030
Why?
Endothelium, Vascular
1
2004
952
0.030
Why?
Lymph Node Excision
1
2019
173
0.030
Why?
Cell Transformation, Viral
1
2017
23
0.030
Why?
Phospholipases A2
1
1997
78
0.030
Why?
GTP-Binding Protein alpha Subunits, Gi-Go
1
1997
20
0.030
Why?
Transducin
1
1997
42
0.030
Why?
Immunomodulation
1
2018
98
0.030
Why?
Organoplatinum Compounds
1
2017
65
0.030
Why?
Cells, Cultured
4
2000
4112
0.030
Why?
Statistics, Nonparametric
1
2018
423
0.030
Why?
Lymphocyte Count
1
2017
166
0.030
Why?
Immunologic Memory
1
2019
369
0.030
Why?
Phospholipases A
1
1997
97
0.030
Why?
Tumor Stem Cell Assay
1
2016
33
0.030
Why?
Oligopeptides
1
1999
264
0.030
Why?
Research Design
1
2003
1139
0.030
Why?
Variant Surface Glycoproteins, Trypanosoma
2
1994
2
0.030
Why?
Otorhinolaryngologic Surgical Procedures
1
2017
38
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2016
43
0.030
Why?
Margins of Excision
1
2017
54
0.030
Why?
Oligonucleotides, Antisense
1
1997
122
0.030
Why?
CpG Islands
1
2017
175
0.030
Why?
Laryngectomy
1
2016
17
0.030
Why?
Viral Core Proteins
1
2016
21
0.030
Why?
Human Papillomavirus DNA Tests
1
2015
1
0.030
Why?
Absorption, Radiation
1
2015
3
0.030
Why?
Antigen Presentation
1
2017
209
0.030
Why?
Orchiectomy
1
2016
72
0.030
Why?
Skin
2
2012
701
0.030
Why?
Causality
1
2016
128
0.030
Why?
Lymphocytes
1
2017
379
0.030
Why?
Neck Dissection
1
2015
16
0.030
Why?
Base Sequence
1
1999
2119
0.030
Why?
Urothelium
1
2015
33
0.030
Why?
Statistics as Topic
1
2016
277
0.030
Why?
Insurance Coverage
1
2017
246
0.030
Why?
Severity of Illness Index
2
2016
2910
0.030
Why?
Phosphatidylinositol Diacylglycerol-Lyase
1
1994
4
0.030
Why?
Age Factors
2
2016
3321
0.030
Why?
Amino Acid Sequence
1
1999
2088
0.030
Why?
Veratrum Alkaloids
1
2014
20
0.030
Why?
Zinc Finger Protein GLI1
1
2014
23
0.030
Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2014
36
0.030
Why?
3T3 Cells
1
1994
152
0.030
Why?
Phosphoric Diester Hydrolases
1
1994
53
0.030
Why?
Muscle, Smooth
1
2015
152
0.030
Why?
RNA, Small Interfering
1
2016
630
0.030
Why?
Mice, Transgenic
1
2019
2131
0.030
Why?
Bevacizumab
1
2015
167
0.030
Why?
Cell Fractionation
1
1994
50
0.030
Why?
Gene Expression
1
2019
1461
0.030
Why?
Smoking
2
2014
1478
0.030
Why?
HeLa Cells
1
2015
635
0.020
Why?
Fatty Acids
2
1994
460
0.020
Why?
Glycerol
1
1994
90
0.020
Why?
Myristic Acids
1
1993
8
0.020
Why?
Receptor, Notch2
1
2013
15
0.020
Why?
Gonanes
1
2013
23
0.020
Why?
Histone Deacetylases
1
2015
208
0.020
Why?
rac GTP-Binding Proteins
1
2013
35
0.020
Why?
rac1 GTP-Binding Protein
1
2013
56
0.020
Why?
Receptor, Notch1
1
2013
62
0.020
Why?
Medicare
1
2019
907
0.020
Why?
Neuropeptides
1
2013
75
0.020
Why?
Chromatography, Thin Layer
1
1992
24
0.020
Why?
Alcohol Oxidoreductases
1
2013
61
0.020
Why?
Epithelial-Mesenchymal Transition
1
2014
218
0.020
Why?
Autoradiography
1
1992
64
0.020
Why?
Penis
1
2012
33
0.020
Why?
Promoter Regions, Genetic
1
2017
1236
0.020
Why?
Erectile Dysfunction
1
2012
35
0.020
Why?
Epigenesis, Genetic
1
2017
705
0.020
Why?
Magnetic Resonance Imaging
1
2005
3917
0.020
Why?
Testis
1
2012
157
0.020
Why?
Nasopharyngeal Neoplasms
1
2011
21
0.020
Why?
Group VI Phospholipases A2
1
2011
6
0.020
Why?
Models, Statistical
1
2015
667
0.020
Why?
Thymidine
1
1991
57
0.020
Why?
HCT116 Cells
1
2011
78
0.020
Why?
TOR Serine-Threonine Kinases
1
2014
454
0.020
Why?
Carboplatin
1
2011
168
0.020
Why?
Comorbidity
1
2016
1652
0.020
Why?
Glioma
1
2015
425
0.020
Why?
Hirudins
1
1991
52
0.020
Why?
Oncogene Proteins, Fusion
1
2013
212
0.020
Why?
Camptothecin
1
2011
139
0.020
Why?
Dinoprostone
1
2011
179
0.020
Why?
Spindle Apparatus
1
2011
92
0.020
Why?
Cone-Beam Computed Tomography
1
2010
32
0.020
Why?
Chymotrypsin
1
1990
23
0.020
Why?
Retreatment
1
2010
79
0.020
Why?
Larva
1
2011
242
0.020
Why?
Erlotinib Hydrochloride
1
2010
71
0.020
Why?
Lipid Metabolism
1
1994
533
0.020
Why?
tert-Butylhydroperoxide
1
2009
9
0.020
Why?
Cytoprotection
1
2009
55
0.020
Why?
Organ Size
1
2010
463
0.020
Why?
Prevalence
1
2016
2852
0.020
Why?
NF-kappa B
1
2013
674
0.020
Why?
Phenotype
1
1997
3186
0.020
Why?
Inositol Phosphates
1
1988
21
0.020
Why?
Gastrostomy
1
2010
123
0.020
Why?
Inositol
1
1988
25
0.020
Why?
Neck
1
2009
107
0.020
Why?
Substrate Specificity
1
2009
387
0.020
Why?
Health Services Accessibility
1
2017
1101
0.020
Why?
Xerostomia
1
2008
13
0.020
Why?
Capecitabine
1
2008
56
0.020
Why?
Premedication
1
2008
45
0.020
Why?
Arachidonic Acids
1
1988
42
0.020
Why?
Movement
1
2010
290
0.020
Why?
Computational Biology
1
2013
675
0.020
Why?
Pharyngeal Neoplasms
1
2007
4
0.020
Why?
Benzimidazoles
1
2009
189
0.020
Why?
Antimetabolites, Antineoplastic
1
2008
108
0.020
Why?
Postoperative Care
1
2010
292
0.020
Why?
Ethanol
1
1992
629
0.020
Why?
Remission Induction
1
2008
308
0.020
Why?
Quality Assurance, Health Care
1
2009
339
0.020
Why?
Adolescent
2
2017
22451
0.020
Why?
Hemoglobin A
1
2007
21
0.020
Why?
Health Transition
1
2007
8
0.020
Why?
Deoxycytidine Kinase
1
2006
3
0.020
Why?
Chromatography, High Pressure Liquid
1
2009
588
0.020
Why?
Tumor Suppressor Protein p53
1
2011
530
0.020
Why?
Registries
1
2016
2382
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2008
178
0.020
Why?
Rats, Sprague-Dawley
1
2012
2533
0.020
Why?
Mouth Mucosa
1
2007
84
0.020
Why?
Transcription Factors
1
2014
1728
0.010
Why?
Gene Amplification
1
2006
116
0.010
Why?
Whole Body Imaging
1
2006
29
0.010
Why?
Enteral Nutrition
1
2008
212
0.010
Why?
Mice, Knockout
1
2013
3121
0.010
Why?
DNA-Binding Proteins
1
2013
1467
0.010
Why?
Breast Neoplasms
1
2018
2411
0.010
Why?
Risk
1
2008
917
0.010
Why?
Structure-Activity Relationship
1
2006
561
0.010
Why?
Laminin
1
2005
72
0.010
Why?
Chromosome Mapping
1
2006
505
0.010
Why?
Infant, Newborn
1
2017
6449
0.010
Why?
Proteoglycans
1
2005
111
0.010
Why?
Transfection
1
2006
914
0.010
Why?
Drug Combinations
1
2005
399
0.010
Why?
Actins
1
2006
422
0.010
Why?
Stearic Acids
2
1994
15
0.010
Why?
Medical Oncology
1
2007
344
0.010
Why?
In Vitro Techniques
1
2005
1041
0.010
Why?
Global Health
1
2007
402
0.010
Why?
Drug-Related Side Effects and Adverse Reactions
1
2006
266
0.010
Why?
Collagen
1
2005
460
0.010
Why?
bcl-X Protein
1
2002
44
0.010
Why?
Infant
1
2017
10093
0.010
Why?
Oxidative Stress
1
2009
1367
0.010
Why?
Societies, Medical
1
2007
901
0.010
Why?
Endothelial Cells
1
2008
876
0.010
Why?
Child, Preschool
1
2017
11888
0.010
Why?
Proto-Oncogene Proteins c-bcl-2
1
2002
237
0.010
Why?
Chromones
1
2000
43
0.010
Why?
Proto-Oncogene Proteins c-akt
1
2002
438
0.010
Why?
Weight Loss
1
2006
857
0.010
Why?
Cyclin-Dependent Kinase 4
1
2000
52
0.010
Why?
Child
1
2017
22638
0.010
Why?
Cell Membrane
1
1980
701
0.010
Why?
Peptides
1
1980
991
0.010
Why?
Glycolipids
1
1994
53
0.010
Why?
Radioisotope Dilution Technique
1
1993
14
0.010
Why?
Tritium
1
1993
64
0.010
Why?
Acetic Acid
1
1993
16
0.010
Why?
Myristic Acid
1
1993
10
0.010
Why?
DNA
1
1980
1418
0.010
Why?
Acetates
1
1993
78
0.010
Why?
Receptors, Cell Surface
1
1980
371
0.000
Why?
Raben's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)